Cargando…
On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon
Clostridium difficile is the most frequently identified enteric pathogen in patients with nosocomially acquired, antibiotic-associated diarrhea and pseudomembranous colitis. Although metronidazole and vancomycin were effective, an increasing number of treatment failures and recurrence of C. difficil...
Autores principales: | Le Lay, Christophe, Fernandez, Benoit, Hammami, Riadh, Ouellette, Marc, Fliss, Ismail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585240/ https://www.ncbi.nlm.nih.gov/pubmed/26441942 http://dx.doi.org/10.3389/fmicb.2015.01020 |
Ejemplares similares
-
Impact of Nisin and Nisin-Producing Lactococcus lactis ssp. lactis on Clostridium tyrobutyricum and Bacterial Ecosystem of Cheese Matrices
por: Hassan, Hebatoallah, et al.
Publicado: (2021) -
Complete Genome Sequence of Nisin-Producing Lactococcus lactis subsp. lactis N8
por: Wan, Xing, et al.
Publicado: (2021) -
Bioengineering of a Lactococcus lactis subsp. lactis strain enhances nisin production and bioactivity
por: Portieles, Roxana, et al.
Publicado: (2023) -
Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000
por: Bahey-El-Din, Mohammed, et al.
Publicado: (2008) -
Subcellular Localization and Assembly Process of the Nisin Biosynthesis Machinery in Lactococcus lactis
por: Chen, Jingqi, et al.
Publicado: (2020)